Integrating EDC with Other Systems: A Case Study with Syngene International
As the adoption of EDC has increased across all phases of clinical trials, it is now recognized as a commodity that is helping companies reduce costs while increasing efficiency and improving trial outcomes. Some of the key differentiators are found in the level of service provided, the flexibility to adapt during the clinical trial and integration with other systems.
Flexibility to integrate with its clients’ systems was one of the key reasons why Syngene, one of the biggest drug discovery and development contract research organizations (CROs), decided to go with ArisGlobal’s EDC solution, agCapture. Syngene also required a randomization and trial supply management (RTSM) solution, which is why they opted for our unified platform. They needed a solution that was configured to their requirements, which the bigger software vendors were simply not offering.
Watch this special session to hear Dr. Anand Eswaraiah, Head of Biometrics, Medical and Regulatory Affairs at Syngene, explain his experiences before adopting our solution, and how this solution solved their challenges. Learn:
Why we need to change the status quo and agree inflexible EDC solutions are a problem, not the solution.
Syngene’s experiences before adopting ArisGlobal’s EDC solution
The benefits flexible solutions bring, including operational improvements in efficiencies as well as reduced study completion times
Please sign up below to view this webinar.